ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
-15.55%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$2.4B
AUM Growth
+$2.4B
(-17%)
Cap. Flow
+$51.9M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
69.51%
Holding
37
New
3
Increased
9
Reduced
7
Closed
3
Top Buys
| 1 |
Karyopharm Therapeutics
KPTI
|
$58.2M |
| 2 |
Pacira BioSciences
PCRX
|
$45.7M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$21.7M |
| 4 |
Sarepta Therapeutics
SRPT
|
$20.9M |
| 5 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$15.6M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$92.7M |
| 2 |
MDCO
Medicines Co
MDCO
|
$27.7M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$15.7M |
| 4 |
Adaptive Biotechnologies
ADPT
|
$9.66M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$8.76M |
Sector Composition
| 1 | Healthcare | 87.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $292M | 12.19% | 3,750,000 -112,500 | -3% | -$8.76M |
|
|
IMMU
2
DELISTED
Immunomedics Inc
IMMU
| $278M | 11.62% | 21,000,000 | – | – |
|
3
Iovance Biotherapeutics
IOVA
$807M
| $193M | 8.05% | 10,601,039 -151,546 | -1% | -$2.76M |
|
4
Ascendis Pharma
ASND
$11.8B
| $190M | 7.92% | 1,970,000 | – | – |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $164M | 6.85% | 2,437,100 +322,100 | +15% | +$21.7M |
|
|
AMRN
6
Amarin Corp
AMRN
$311M
| $129M | 5.39% | 8,520,000 +1,020,000 | +14% | +$15.5M |
|
|
7
Sarepta Therapeutics
SRPT
$1.78B
| $126M | 5.27% | 1,678,000 +278,000 | +20% | +$20.9M |
|
|
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $109M | 4.54% | 4,000,000 | – | – |
|
9
argenx
ARGX
$43.6B
| $95.2M | 3.97% | 835,000 -5,000 | -0.6% | -$570K |
|
10
Amicus Therapeutics
FOLD
$2.34B
| $89M | 3.71% | 11,100,000 +1,100,000 | +11% | +$8.82M |
|
|
MYOK
11
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $81M | 3.38% | 1,552,700 +177,700 | +13% | +$9.27M |
|
|
ZGNX
12
DELISTED
Zogenix, Inc.
ZGNX
| $75.1M | 3.13% | 1,875,000 -150,000 | -7% | -$6.01M |
|
|
ATNX
13
DELISTED
Athenex, Inc. Common Stock
ATNX
| $71.7M | 2.99% | 5,890,000 +1,285,000 | +28% | +$15.6M |
|
|
TCDA
14
DELISTED
Tricida, Inc. Common Stock
TCDA
| $67.9M | 2.83% | 2,200,000 | – | – |
|
|
15
Pacira BioSciences
PCRX
$1.2B
| $60.9M | 2.54% | 1,600,000 +1,200,000 | +300% | +$45.7M |
|
|
16
Karyopharm Therapeutics
KPTI
$61.7M
| $58.2M | 2.43% | +6,050,000 | New | +$58.2M |
|
|
GBT
17
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $48.5M | 2.02% | 1,000,000 +50,000 | +5% | +$2.43M |
|
|
18
Acadia Pharmaceuticals
ACAD
$4.38B
| $31.9M | 1.33% | 887,500 -437,500 | -33% | -$15.7M |
|
|
BDSI
19
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $31.3M | 1.3% | 7,424,867 | – | – |
|
20
Madrigal Pharmaceuticals
MDGL
$9.76B
| $31M | 1.29% | 360,000 | – | – |
|
21
Allogene Therapeutics
ALLO
$251M
| $30.8M | 1.28% | 1,128,594 | – | – |
|
22
Adverum Biotechnologies
ADVM
$64.6M
| $23.2M | 0.97% | 4,250,000 +750,000 | +21% | +$4.09M |
|
23
PTC Therapeutics
PTCT
$3.92B
| $23.1M | 0.97% | 684,000 | – | – |
|
24
Xenon Pharmaceuticals
XENE
$2.98B
| $21.6M | 0.9% | 2,400,000 | – | – |
|
|
MDCO
25
DELISTED
Medicines Co
MDCO
| $18.6M | 0.78% | 371,623 -553,377 | -60% | -$27.7M |
|